Application of magnetic resonance imaging for monitoring stem cell transplantation for the treatment of cerebral ischemia

Neural Regeneration Research

Volumn 7, Issue 16, 2012, Pages 1264-1271

  Zhang, Xianglin ^a   Wang, Gang ^a   Dong, Furen ^a   Wang, Zhiming ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow mesenchymal stem cells; Cell transplantation; Cerebral ischemia; Embryonic stem cells; Neural regeneration; Neural stem cells; Web of science

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

BIBLIOMETRICS; BRAIN ISCHEMIA; HUMAN; MEDICAL LITERATURE; MESENCHYMAL STEM CELL TRANSPLANTATION; MONITORING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PUBLICATION; REVIEW;

EID: 84864383934     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Chang YC, Shyu WC, Lin SZ, et al. Regenerative therapy for stroke. Cell Transplant. 2007;16(2):171-181.
2. Bang OY, Lee JS, Lee PH, et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol. 2005;57(6):874-882.
3. Kraitchman DL, Gilson WD, Lorenz CH. Stem cell therapy: MRI guidance and monitoring. J Magn Reson Imaging. 2008;27(2):299-310.
4. Weissleder R. Molecular imaging: exploring the next frontier. Radiology. 1999;212(3):609-614.
5. Bulte JW, Douglas T, Witwer B, et al. Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents. Acad Radiol. 2002; 9(2): S332-S335.
6. Sehoefer R, KeMbach R, Wiskirchen J, et al. Transferrin respector upregulation: in vitro labeling of rat mesenchymal stem cells with superparamagnetic iron oxide. Radiology. 2007;244(2):514-523.
7. Frank JA, Zywicke H, Jordan EK, et al. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. Acad Radiol. 2002;9(2):S484-S487.
8. Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetie iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology. 2003; 229(3):838-846.
9. Arbab AS. Yoeum GT, Wilson LB, et al. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging. 2004;3(1):24-32
10. Norman AB, Thomas SR, Pratt RG, et al. Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent. Brain Res. 1992; 594(2):279-283.
11. Stoll G, Wesemeier C, Gold R, et al. In vivo monitoring of macro-phage infiltration in experimental autoimmune neuritis by magneticresonance imaging. J Neuroimmunol. 2004;149(1-2):142-146.
12. Chen ZC, Xu RX, Yang ZJ, et al. Sinerem labeling and MRI tracking of neural stem cells in vivo and in vitro. Nanfang Yike Daxue Xuebao. 2007;27(5):611-615.
13. Chung DJ, Choi CB, Lee SH, et al. Intraarterially delivered human umbilical cord blood-derived mesenchymal stem cells in canine cerebral ischemia. J Neurosci Res. 2009; 87(16):3554-3567.
14. Wollert KC, Meyer GP, Lotz J, et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364(9429):141-148.
15. Bjorklund LM, Sánchez-Pernaute R, Chung S, et al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci U S A. 2002;99(4): 2344-2349.
16. Lunde K, Solheim S, Aakhus S, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355(12): 1199-1209.
17. Schächinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004;44(8):1690-1699.
18. Corot C, Robert P, Idée JM, et al. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev. 2006;58(14):1471-1504.
19. Hoehn M, Küstermann E, Blunk J, et al. Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A. 2002;99(25):16267-16272.
20. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003;107(18): 2290-2293.
21. de Vries IJ, Lesterhuis WJ, Barentsz JO, et al. Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol. 2005; 23(11):1407-1413.
22. Bulte JW, Kraitchman DL. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed. 2004;17(7):484-499.
23. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology. 2003;228(2):480-487.
24. Arbab AS, Bashaw LA, Miller BR, et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology. 2003;229(3):838-846.
25. Lu CW, Hung Y, Hsiao JK, et al. Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling. Nano Lett. 2007;7(1):149-154.
26. Bulte JW, Duncan ID, Frank JA. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab. 2002;22(8): 899-907.
27. Kostura L, Kraitchman DL, Mackay AM, et al. Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed. 2004;17(7):513-517.
28. Kurozumi K, Nakamura K, Tamiya T, et al. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther. 2004; 9(2):189-197.
29. Honma T, Honmou O, Iihoshi S, et al. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol. 2006;199(1):56-66.
30. Horita Y, Honmou O, Harada K, et al. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res. 2006;84(7):1495-1504.
31. Onda T, Honmou O, Harada K, et al. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab. 2008;28(2):329-340.
32. Zhang Z, Jiang Q, Jiang F, et al. In vivo magnetic resonance imaging tracks adult neural progenitor cell targeting of brain tumor. Neuroimage. 2004;23(1): 281-287.
33. Chopp M, Zhang ZG, Jiang Q. Neurogenesis, angiogenesis, and MRI indices of functional recovery from stroke. Stroke. 2007;38(2 Suppl):827-831.
34. Li L, Jiang Q, Ding G, et al. Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab. 2010;30(3):653-662.
35. Toyama K, Honmou O, Harada K, et al. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia. Exp Neurol. 2009;216(1):47-55.
36. Omori Y, Honmou O, Harada K, et al. Optimization of a therapeutic protocol for intravenous injection of human mesenchymal stem cells after cerebral ischemia in adult rats. Brain Res. 2008;1236:30-38.